12 unknown, 10 completed, 6 recruiting, 1 active not recruiting. 6 Phase 2, 5 Phase 4, 4 Not applicable, 2 Phase 3, 1 Phase 1.
Follow Coronary Aneurysm: new trials by email Literature Review of Coronary Aneurysm trials Research Report on Coronary Aneurysm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ischemia and Inflammatory Markers Among Patients With Coronary Artery Ectasia stress ECG - Coronary Artery Ectasia | Not yet recruiting | Assiut University | 90 | 2026-08-01 | 2026-07-28 | |
| Progression, Management, and Clinical Outcomes of Coronary Artery Aneurysms Coronary Artery Disease, Aneurysms | Recruiting | Nanjing First Hospital, Nanjing Medical University | 1000 | 2026-07-31 | 2026-08-13 | |
| Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia Aspirin 100 mg, Clopidogrel 75 mg, Rivaroxaban 15 mg - Coronary Artery Ectasia, Acute Coronary Syndromes (ACS) | Phase 4 | Recruiting | Instituto Nacional de Cardiologia Ignacio Chavez | 326 | 2026-02-11 | 2026-04-09 |
| Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease Rivaroxaban Oral Tablet [Xarelto], Aspirin or Clopidogrel, Warfarin - Kawasaki Disease, Coronary Artery Aneurysm | Phase 4 | Recruiting | Children's Hospital of Fudan University | 100 | 2025-06-01 | 2026-07-06 |
| Middle East Coronary Artery Ectasia Registry non interventional study - Coronary Artery Ectasia | Recruiting | Jordanian Research and Artificial Intelligence Group | 11000 | 2024-09-01 | 2025-05-04 | |
| Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki Disease Rivaroxaban (Xarelto) - Kawasaki Disease, Pilot Study | Phase 4 | Recruiting | Children's Hospital of Fudan University | 10 | 2024-01-10 | 2026-10-22 |
| Use of Coils During Percutaneous Coronary Intervention Percutaneous Coronary Intervention (PCI), Coronary Artery Disease | Completed | San Luigi Gonzaga Hospital | 143 | 2024-01-01 | 2024-12-06 | |
| Coronary Artery Ectasia Database - Poland Coronary Artery Aneurysm, Coronary Artery Ectasia | Unknown | Poznan University of Medical Sciences | 2000 | 2023-07-14 | 2023-09-29 | |
| Coronary Artery Ectasia, Efficacy of Various Anti Thrombotic Regimens. Rivaroxaban 2.5 Mg Oral Tablet twice daily, Clopidogrel 75 Mg Oral Tablet, Aspirin tablet 75 mg - Coronary Artery Ectasia | Phase 3 | Unknown | Assiut University | 200 | 2023-02-01 | 2023-02-08 |
| Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years Kawasaki Disease, Coronary Artery Aneurysm | Recruiting | Children's Hospital of Fudan University | 60 | 2023-01-01 | 2025-05-29 | |
| Outcomes After PCI of the Aneurysmatic Right Coronary Artery Percutaneous Coronary Intervention - Coronary Disease, Coronary Artery Ectasia | Unknown | San Luigi Gonzaga Hospital | 90 | 2022-11-01 | 2023-04-18 | |
| Whole Exome Sequencing in Coronary Artery Ectasia Whole exome sequencing - Coronary Ectasia, Coronary Aneurysm | Completed | Jagiellonian University | 1 | 2022-03-23 | 2023-08-21 | |
| Inflammation and Clotting Abnormalities in Aneurysmal Coronary Artery Disease Evaluation of inflammation and clotting - Coronary Artery Aneurysm, Abdominal Aortic Aneurysm | Unknown | John Paul II Hospital, Krakow | 180 | 2022-01-10 | 2022-01-10 | |
| Arrhythmogenic Risk Assessment in Coronary Artery Ectasia Patients Holter, ECG - Coronary Artery Ectasia | Unknown | Assiut University | 90 | 2022-01-01 | 2021-11-03 | |
| Antithrombotic Therapy in Acute Coronary Syndromes and Coronary Artery Ectasia Rivaroxaban 15 MG, Acetylsalicylic acid 100mg, Clopidogrel 75 Mg Oral Tablet - Acute Coronary Syndrome, Coronary Artery Ectasia | Phase 2 | Unknown | Instituto Nacional de Cardiologia Ignacio Chavez | 60 | 2021-09-01 | 2022-02-10 |
| Endothelial NO Synthase Polymorphic Gene in Coronary Artery Dilation Disease The specific genetic PCR laboratory test were performed for all selected patients for eNOS SNPs - Coronary Artery Ectasia | Completed | Cairo University | 100 | 2020-12-01 | 2024-01-25 | |
| Methylprednisolone Pulse Therapy for Coronary Artery Dilatation or Aneurysm Formation in Kawasaki Disease Methylprednisolone Injection - Mucocutaneous Lymph Node Syndrome | Phase 1 | Unknown | Chang Gung Memorial Hospital | 10 | 2020-04-15 | 2020-08-11 |
| A New Classification and Interventional Therapy for Coronary Artery Ectasia Single BMS, Single or Double BMS, BMS+DES - Coronary Artery Ectasia | Not applicable | Unknown | China National Center for Cardiovascular Diseases | 100 | 2019-11-01 | 2020-02-17 |
| Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease Canakinumab - Kawasaki Disease | Phase 2 | Withdrawn | Novartis Pharmaceuticals | 2016-11-15 | 2017-02-17 | |
| Evaluation of Emotional Status and Coronary Flow Characteristics by TIMI Frame Count Method coronary angiography - Coronary Artery Disease, Coronary Artery Ectasia | Not applicable | Unknown | Ertan YETKIN | 2000 | 2016-07-01 | 2016-07-13 |
Showing 20 of 31. Sign in to see all of them.
Mucocutaneous Lymph Node Syndrome (9) · Acute Coronary Syndrome (4) · Coronary Artery Disease (4) · Coronary Disease (3) · Cardiovascular Diseases (2) · Heart Diseases (2) · No-Reflow Phenomenon (2) · ST Elevation Myocardial Infarction (2) · Aneurysm (1) · Anxiety Disorders (1) · Aortic Aneurysm, Abdominal (1) · Death (1) · Depression (1) · Heart Failure (1)
Myocardial Ischemia (31) · Vascular Diseases (31) · Aneurysm (30) · Cardiovascular Diseases (29) · Heart Diseases (29) · Coronary Disease (28) · Hemic and Lymphatic Diseases (9) · Lymphatic Diseases (9) · Skin Diseases (9) · Skin Diseases, Vascular (9) · Skin and Connective Tissue Diseases (9) · Vasculitis (9) · Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6) · Arterial Occlusive Diseases (4)
Aspirin (5) · Rivaroxaban (5) · Clopidogrel (4) · Immunoglobulins, Intravenous (2) · Tablets (2) · Atorvastatin (1) · Bleeding Time (1) · Doxycycline (1) · Electrocardiography, Ambulatory (1) · Exome (1) · Genetic Testing (1) · Infliximab (1) · Interleukin 1 Receptor Antagonist Protein (1) · Methylprednisolone (1) · Percutaneous Coronary Intervention (1)
Assiut University (3) · Children's Hospital of Fudan University (3) · Instituto Nacional de Cardiologia Ignacio Chavez (2) · San Luigi Gonzaga Hospital (2) · Ankara University (1) · Assistance Publique - Hôpitaux de Paris (1) · Bursa Postgraduate Hospital (1) · Cairo University (1) · Carelon Research (1) · Chang Gung Memorial Hospital (1) · China National Center for Cardiovascular Diseases (1) · Ertan YETKIN (1) · Hawaii Pacific Health (1) · Jagiellonian University (1) · Jeil Pharmaceutical Co., Ltd. (1)
China (5) · Poland (3) · Turkey (Türkiye) (3) · Egypt (2) · Italy (2) · Mexico (2) · Spain (2) · Taiwan (2) · France (1) · Israel (1) · Jordan (1) · United States (1)
Fang Liu, MD (3) · Ahmed Mowafy, MD (1) · Alexandra Arias Mendoza, MD (1) · Aly M. Tohamy, MD (1) · Andras Bratincsak, MD PhD (1) · Diego Araiza Garaygordobil, MD, MSc (1) · Fred Rosen (1) · Hamdy S. Mohammad, MD (1) · Hyo-soo Kim, Professor (1) · Lynn Sleeper, ScD. (1) · Mahmoud A. Abdallah, MD (1) · Mahmoud I Izraiq, MD, FACC, FSCAI (1) · Ming-Tai Lin, MD (1)
PMID 17301297, PMID 19038400, PMID 21168857, PMID 21185506, PMID 28337781, PMID 29313803, PMID 31378382, PMID 32779863, PMID 32902099, PMID 34910278, PMID 35904750, PMID 37660376, PMID 38299468, PMID 39181812, PMID 39615618, PMID 41121637
2014 (1), R01HL034545 (1), U01HL068270 (1)